In thisprospectivefollow-up investigation, we examinedthe efficacy ofa modified Politzer device in the home treatment of persistent middle ear effusion (MEE) and associated hearing loss in children who had previously participated in a similar clinical trial. Our study group was made up of 38 patients who had been either (I) untreated control participants in the previous study whose hearing in one or both ears had not returned to normal within II weeks of their initial audiolo gic pretest (''former control group "; n = 30), or (2) active-treatment participants in the previous study whose hearing sensitivity in at least one ear had not improved to within normal limits after treatment and who elected to undergo a continuation of treatment ( "extended-treatment group "; n = 8). Treatment efficacy was determined by comparing differences in pre-and posttreatment air-conduction thresholds and otoscopic findings . Following treatment, the former control group experienced significant improvements in hearing sensitivity at all frequ encies; at the posttreatment test, hearing sensitivity was within normal limits in 43 of60 ears (71.7%), and normal or moderate tympanic membrane mobility was observed in 30 of34 otoscopically examined ears (88.2%).
Introduction
We recently reported the results of arandomized controlled clinical trial of a modified Politzer device for the home treatment of persi stent middle ear effusion (MEE) and associated hearing loss .1 Our handheld, battery-operated device emits controlled air pressure and air flow that can be adjusted in accordance with the degree of hearing loss and the patient's age.
In our previous study, we found that twice-daily home treatment over a period of7 weeks was highly efficacious in restoring hearing in children between the ages of 4 and II years who had MEE . At the posttreatment audiologic test, hearing sensitivity had returned to normal in 65 of 88 treated ears (73.9%) and in at least one ear in 40 of 47 treated patients (85.1 %); the corresponding figures for the control group were only 23 of 86 (26.7 %) and 15 of 47 (31.9%).Wealso reported that pneumatic otoscopy revealed normal or moderate tympanic membr ane mobility in 61 of 65 successfully treated ears (93.8 %).1 At the conclusion of our previou s study, we offered the controls whose hearing had not recovered the opportunity to undergo active treatment. We also offered extended treatment to those patients in the active-treatment group who had not completely improved. In this article, we report the findings of our prospective follow-up study.
Patients and methods
Instrumentation. The design and function of our modified Politzer device are described in the report of our prev i-SILMAN, ARICK, EMMER ous study.' The device emits a controlled air pressure and volume velocity sufficient to effect improvement without discomfort. The device has two settings. Setting number I delivers an air pressure of 5.2 psi at a volume velocity of 1,524 ml/min ; setting 2 delivers an air pressure of 2.5 psi at a volume velocity of 1,690 ml/min. The device was very similar to one that we had used in two other studies reported in 1999 2 and 2000 . 3 Patients. Our study population was made up of patients who had furnished informed consent and who satisfied six study criteria: (I) age 4 to II years , (2) at least a 2-month history ofMEE and associated hearing loss as documented by a physician, (3) pure-tone air-conduction thresholds of 20 dB HL or more at 3 frequencies between 500 and 4,000 Hz with air-bone gaps of 15 dB or more at these frequencies or pure-tone air-conduction thresholds of 25 dB HL or more at 2 frequencies between 500 and 4,000 Hz with air-bone gaps of 15 dB or more at these frequencies at the final pretest, (4) a tympanometric peak pressure of -100 daPa or less at the final pretest, (5) an otologic diagnosis ofMEE at the final pretest, and (6) an absence of enlarged adenoids, acute otitis media, and other ear abnormalities at the final pretest otologic examination.
Former control group. At the completion of our previous study, 32 of the 47 controls had not achieved normal hearing in at least one ear. Ofthese 32 patients, 30 accepted our offer to undergo active treatment.
Extended-treatment group . Eight patients in the activetreatment group ofour previous study who had not achieved recovery of hearing in one or both ears accepted our offer to continue treatment in the current study.
Procedures. The procedures used in this study were the same as those followed in our previous report, except that we did not include any untreated controls. All patients in this follow-up study received active treatment.
Each patient's parent administered treatment in the morning before breakfast and again in the evening after supper. Each participant had his or her own device. The parent was given alcohol-soaked wipes and instructed to clean the tip of the pediatric probe , which was coupled to the device, before each use. During each treatment, the patient was instructed to be in a sitting position. To deliver therapy, the parent inserted the tip into one nostril while compressing the other nostril with a finger (figure). The child then held a small amount of water in the mouth without swallowing it. The parent then turned on the device, thereby introducing air flow into the nostril at a con stant volume velocity. After I or 2 seconds of air flow, the parent asked the child to swallow the water. Immediately thereafter, the same therapy was admini stered to the other nostril. Approximately 10 minutes later, the procedure was repeated in both nostrils. (Note: Our description of the treatment protocol in part I of this article' was incorrect. See "Erratum" on page 614 of this issue .)
The planned duration of treatment for the former control 648 Figure. The parent inserts the tip of the modified Politzerdevice into one nostril while she comp resses the other nostril with her fing er:
group was 7 weeks .The patients in the extended-treatment group (who had already received 7 weeks of treatment) were scheduled to undergo an additional 2 weeks of treatment. Two weeks after the completion of extended treatment, they underwent an audiologic assessment. Those who se hearing was not within normal limits in one or both ears were given another 2 weeks oftreatment and assessed again 2 weeks after its completion. This treatment-and-assessment cycle continued until either hearing sensitivity was restored to within normal limits or no further improvement in hearing sensitivity was observed. Parents were provided with a daily log to foster and track compliance. Most patients were seen in the office for monitoring at least once near the midpoint of the treatment period. Parents were advised to discontinue treatment if the child developed a head cold or infection and to resume treatment only after obtaining clearance from a study otologist or the child 's pediatrician.
Audiometry was performed by audiologists certified by the American Speech-language-Hearing Association and licensed by New York State. Otologic evaluations were performed by board-certified otolaryngologists with at least 15 years of experience. Audiologic evaluations (air-and bone-conduction threshold testing) and otolaryngologic evaluations (otoscopy) had been performed on all patients upon their enrollment in the previous study. Follow-up audiologic and otologic evaluations were performed at the midpoint oftreatment for the former controls and biweekly during treatment for the extended-treatment patients. The final audiologic and otologic evaluations were conducted on all patients 4 weeks after the completion of each patient's final treatment. Hearing sensitivity was judged to be within normal limits if the air-conduction thresholds were less than 20 dB HL at any of 3 frequencies between 500 and 4,000 Hz or less than 25 dB HL at either of 2 of these frequencies .
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Results
Former control group. Of the 30 former controls, 27 underwent 7 weeks of treatment and 3 underwent 9 weeks . We obtained pre-and posttreatment mean air-conduction thresholds (pretest and posttest, respectively) in both ears in the former controls and com pared them with the same values for the active-treatment gro up in the previous study (table I) . The pretest values for the former controls were obtained 11 weeks following their enro llment in the previous study, and their posttes t values were obtained 4 weeks following the completion of treatment in the current study. The mean pretest air-conduction thresholds in the 2 groups were within 4.6 dB at500 Hz, within 5.0 dB at 1,000 Hz, within 3.0 dB at 2,000 Hz, and within 2.7 dB at 4,000 Hz. In the former control group, mean pretest 4-frequency pure-tone averages were 28.5 and 28.8 dB HL in the right and left ears, respectively; in the previous active-treatment gro up, the correspond ing figures were 29.6 and 32.6 dB HL. Thu s, the mean pure-tone averages were symmetrical within 4.1 dB for both ears of both gro ups.
Analysis of the mean differences in pre-and posttest airco nduction thresholds for both ears in the former control group revealed that treatment resulted in a statistically 650 significant (p < 0.001 ) improvement in hearing in both ears, ranging from 10.3 to 16.3 dB, across the frequency range (table 2) .
We conducted between-group comparisons to determine if treatment was more or less effective in the former control gro up than it had been in the active-treatment group in the previous study. We found no statistically significant differences (table 3) . Thi s finding can be interpreted as supporting the reliability of the findings reported in our previous study.
Hearing sensitivity. In the current study, recovery of hearing sensitivity to within normal limit s follow ing treatment occurred in 43 of the 60 ears (71.7%) in the former control gro up. Results of the previous study were similar, as active treatment restored hearing in 65 of 88 ears (73.9%).1
Otoscopic findings. We performed posttest pneumatic otosco py in 34 of the 43 ears in the for mer control group in which hearing had been restored to within normal limits. Of these 34 ears, tymp anic memb rane mobility was found to be normal in 29 (85.3%), moderate in 1 (2.9%), slight in 3 (8.8%), and absen t in 1 (2.9%). Overall, norm al or moderate tympanic memb rane mobility was observed in 30 of these ears (88.2%). In our previous study, normal or moderate tympanic membrane mobility was observe d in 6 1of65 ears (93.8%).1 Th is similarity further substantiates the efficacy of our dev ice in improv ing middle ear func- Th erefore, the co ntribution of spontaneo us recovery to the improve ment observed ca nnot be entirely ruled out.
Recall that the former co ntrol group and the extende d-treatment group demonstrated close similarity in pretreatm ent air-con duction thres ho lds and in several other measure s, includ ing the degree of improve ment fro m pre -to pos ttest, the percentages of ea rs demonstrating recovery of heari ng sensitiv ity to within nor mal limits at the pos ttest , and the percentages of ears with normal-to-moderate tympa nic mem brane mobility. The close similarity between the two gro ups in (I) pretest hearing sens itivity, (2) the degree of improvement fro m pre-to pos ttes t, (3) the percent ages of ears demonstrating recovery of hearing sens itivity within to norma l limits at the posttest, (4) the subs tan tial and sign ificant (p < 0.00 I) improvement in hearing sensitivity from pre-to posttest, and (5) the lack of change in hearing sensitivity in the former control gro up throughout the I I-week period in our previous study followed by improvement only after initiation of the home treatment (wit h increasingly gre ater improvement observed with the progression of treat ment as evidenced by the res ults of Ear 500 Hz 1,000 Hz 2,000 Hz 4,000 Hz
Right -1.9 -2.8 -5.6 -3.6 (-7.4, 3.5) (-8 .5,2.9) (-11.3 ,0.1 ) (-10.2,2.9) p = 0.48 p = 0 .33 p= 0.053 p=0.28
Tab le 3. M ean (95% con fidence interval) differences between groups (values for t he previous study's active-treatment group minus values for the current study's former con trol group) in the changes (posttest minus pre test) in air-conduction thresholds (d B HL )* 500 Hz -1 2.8 (-17.5, -8.1 ) -12.0 (-15.6, -8.4) Ear tio n and hearing sensitivity in childre n with MEE, and it further supports the Table 2 . Mean (95% confidence interval) differences (posttest minus pretest) in air-conduction thresholds (dB H L) in the 30 former controls' reliability of the findi ngs reported in our previo us study.
Ex tended-treatme nt group. Th e durati on of exten ded treatment ranged Right fro m 2 t0 4 weeks , bringing the total duration of all treatm ent to 9 to I I weeks.
We compared the pur e-tone thresholds Left obtained followi ng the completion of the initial treatment and the completion of exte nded treatment.
Follo wing the initial treatm ent period , 6 of these patients had a unilatera l hearing impairment (patients 2, 3, 4, 5, 6, and 7) and 2 patients had a bilatera l hearing impai rme nt (patients I and 8)-a total of 10 impaired ea rs (table 4) . Following extended treatmen t, normal hearing was restored in 9 of the 10 ears (90.0 %) . Normal hearing was restored in 5 of the 6 patients with unil ateral impairmen t and in both ears of the 2 patients with bilatera l impairment.
When the numb er of ea rs that recovered after initial plus exten ded treatme nt (9) is added to the number that recovered after the initial treatment (65), norm al hearing ove rall was restored in a total of 74 of 88 ears (84 . 1%).
Follow-up. Upon the co mpletion of their ch ildre n's par ticipa tion in the curren t study, parents were advise d to notify the investigators if they or others noticed any change in hearing status. One parent of a former control whose heari ng was restored to within normal limits contacte d us 1 mon th later to report a recurrence of the child's hearing impairment. Audio logic and otologic eval uatio ns reve aled that this child had expe rienced a recurre nce of MEE. The parent was instructed to res ume trea tment for 3 weeks and to retu rn for eva lua tion 2 weeks after the completion of that treatm ent. Altho ugh the treatment was completed, the parent and patient did not retu rn until 4 month s later. At that time, the child's hearing was norm al in both ears .
In the report of our previous study, we noted that 3 childre n whose heari ng had been restore d by treat men t subsequently experienced recurrent MEE with hearing loss. Th e hearing in all 3 of those patients returned to withi n normal limits after treat ment had been reinstituted for 2 weeks. These findings suggest that the use of our modified Politzer dev ice may be effec tive for the treatm ent of recurrent MEE in patients who have already res ponded to previous treatment. Larger studies are needed to confirm the efficac y of our device in treating recurrences . ' :' Statistical significance \l'as determ ined according to ( 
Discussio n
A limitation of this investigation was the absence of a control gro up.Thi s study, however, represents a follow-u p of the partici pants from our previous study whose hearing sensitivity did not recover to within normal limits following treatm ent,' so we did not recruit ano ther control grou p. t Current study. Posttest was perform ed 2 weeks f ollowing the conclusion ofextended treatment.
Left
monitoring during the treatment) suggests that the major factor accounting for the improveme nts seen at the posttest was home treatmen t rather than spontaneo us recovery. In a recent prospective follow-up study of childre n with persistent MEE and hearing loss who had been treated early in life with tymp anostomy tubes, Valtonen et al concluded that parents must be advised of the necessity of lengthy (5 yr) follow -up monitoring, the possible need for repeated surgical placement of tympanostomy tubes, and the possibility that middle ear complications may require other surgical management.' Use of our device might serve as an alternative to repeated surgical insertions of ventilation tubes; furth er research is needed to investigate this possibility.
In conclusion, the findings of our current study further substantiate the efficacy of our modified Politzer device in improv ing middle ear function and hea ring sensitivity in children with MEE, and they support the reliability of the findings of our previo us study.
